SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-114898
Filing Date
2016-04-28
Accepted
2016-04-28 07:26:18
Documents
7
Period of Report
2016-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-9510_18k.htm 8-K 24525
2 EX-99.1 a16-9510_1ex99d1.htm EX-99.1 318778
3 GRAPHIC g95101mm01i001.gif GRAPHIC 2578
4 GRAPHIC g95101mm09i001.gif GRAPHIC 2573
5 GRAPHIC g95101mm05i001.gif GRAPHIC 2573
6 GRAPHIC g95101mm03i001.gif GRAPHIC 2573
7 GRAPHIC g95101mm07i001.gif GRAPHIC 2573
  Complete submission text file 0001104659-16-114898.txt   362877
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 161597124
SIC: 2834 Pharmaceutical Preparations